Steven W. Lefkowitz - 12 Jan 2026 Form 4 Insider Report for CorMedix Inc. (CRMD)

Reporting relationship: Director
Issuer ticker: CRMD
Reported as of: 12 Jan 2026
Net transaction value: +$84,450
SEC form: 4
Accepted by SEC: 14 Jan 2026, 21:30:02 UTC
Prior SEC filing: 10 Dec 2025
Next SEC filing: 27 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Beth Zelnick Kaufman, attorney-in-fact

Key filing fact

Steven W. Lefkowitz filed Form 4 for CorMedix Inc. (CRMD) on 14 Jan 2026.

Key facts

This page summarizes Steven W. Lefkowitz's Form 4 filing for CorMedix Inc. (CRMD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Jan 2026, 21:30.

Change

Previous filing in this sequence was filed on 10 Dec 2025.
Current net transaction value: +$84,450.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001313149 Primary reporting owner

Lefkowitz Steven W

Relationship: Director
Address: C/O CORMEDIX INC.,, 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS
Signature: /s/ Beth Zelnick Kaufman, attorney-in-fact
Signature date: 14 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRMD transaction

Common Stock

Options Exercise

Transaction value: $84,450
Shares: +15,000
Change %: +19%
Price: $5.63
Shares after: 95,498
Date: 12 Jan 2026
Ownership: Direct
Footnotes: F1

CRMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 30,152
Date: 12 Jan 2026
Ownership: Wade Capital Corporation Money Purchase Plan
Footnotes: F2

CRMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,000
Date: 12 Jan 2026
Ownership: Reporting Person's Wife

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRMD transaction Derivative

Stock Option (Right to Buy Common Stock)

Options Exercise

Transaction value: $0
Shares: -15,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 12 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $5.63
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Reporting Person acquired stock through the exercise of options granted on 02/25/2020. The Reporting Person paid the exercise price in cash. No sales of stock were made.

Footnote F2

The Reporting Person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which the Reporting Person has voting and investment control).

Footnote F3

These stock options, representing a right to purchase 15,000 shares of Common Stock, were granted on 02/25/2020. These stock options are fully vested.

SEC remarks

Exhibit 24.1 - Power of Attorney